Radioiodine 131I treatment for large nodular goiter: Recombinant human thyrotropin allows the reduction of Radioiodine 131I activity to be administered in patients with low uptake

Thyroid

Volumn 21, Issue 7, 2011, Pages 759-764

  Ceccarelli, Claudia ^a   Antonangeli, Lucia ^a   Brozzi, Federica ^a   Bianchi, Francesca ^a   Tonacchera, Massimo ^a   Santini, Pierina ^a   Mazzeo, Salvatore ^a   Bencivelli, Walter ^a   Pinchera, Aldo ^a   Vitti, Paolo ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 123; LIOTHYRONINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RECOMBINANT PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG POTENTIATION; DRUG UPTAKE; FEMALE; HUMAN; MALE; NODULAR GOITER; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; MIDDLE AGED;

AGED; AGED, 80 AND OVER; FEMALE; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RECOMBINANT PROTEINS; THYROTROPIN;

EID: 79959812003     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0088     Document Type: Article

References (22)

1. Silva MN, Rubio IG, Romão R, Gebrin EM, Buchpiguel C, Tomimori E, Camargo R, Cardia MS, Medeiros-Neto G 2004 Administration of a single dose of recombinant human thyrotropin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf) 60:300-308. (Pubitemid 38297119)
2. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, Grupe P, Hegedus L 2006 Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 166:1476-1482. (Pubitemid 44125866)
3. Bonnema SJ, Nielsen VE, Boel-Jorgensen H, Grupe P, Andersen PB, Bastholt L, Hegedus L 2007 Improvement of goiter volume reduction after 0.3mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial. J Clin Endocrinol Metab 92:3424-3428. (Pubitemid 47435314)
4. Nielsen VE, Bonnema SJ, Boel-Jorgensen H, Veje A, Hegedus L 2005 Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J Clin Endocrinol Metab 90:79-83. (Pubitemid 40116637)
5. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA 2001 Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters J Clin Endocrinol Metab 86:5330-5336. (Pubitemid 33070255)
6. Albino CC, Mesa CO, Jr., Olandoski M, Ueda CE, Woellner LC, Goedert CA, Sousa AM, Graf H 2005 Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine. J Clin Endocrinol Metab 90:2775-2780. (Pubitemid 40686323)
7. Fast S, Nielsen VE, Grupe P, Bonnema SJ, Hegedü s L 2009 Optimizing 131I uptake after rhTSH stimulation in patients with nontoxic multinodular goiter: evidence from a prospective, randomized, double-blind study. J Nucl Med 50: 732-737.
8. Hegedus L, Hansen BM, Knudsen N, Hansen JM 1988 Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goitre. Br Med J 297:661-662.
9. Nygaard B, Hegedus L, Gervill M, Hjalgrim H, Soe-Jensen P, Hansen JM 1993 Radioiodine treatment of multinodular non-toxic goitre. Br Med J 307:828-832. (Pubitemid 23281746)
10. Huysmans DA, Hermus AR, Corstens FH, Kloppenborg PW 1993 Long-term results of two schedules of radioiodine treatment for toxic multinodular goitre. Eur J Nucl Med 20:1056-1062. (Pubitemid 23353796)
11. Huysmans DA, Nieuwlaat WA, Erdtsieck RJ, Schellekens AP, Bus JW, Bravenboer B, Hermus AR 2000 Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter. J Clin Endocrinol Metab 85:3592-3596.
12. Nieuwlaat WA, Huysmans DA, van den Bosch HC, Sweep CG, Ross HA, Corstens FH, Hermus AR 2003 Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 88:3121-3129. (Pubitemid 36877482)
13. Cohen O, Ilany J, Hoffman C, Olchovsky D, Dabhi S, Karasik A, Goshen E, Rotemberg G, Zwas ST 2006 Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 154:243-252.
14. Paz-Filho GJ, Mesa-Junior CO, Olandoski M, Woellner LC, Goedert CA, Boguszewski CL, Carvalho GA, Graf H 2007 Effect of 30 mCi radioiodine on multinodular goiter previously treated with recombinant human thyroid-stimulating hormone. Brazil J Med Biol Res 40:1661-1670.
15. Duick DS, Baskin HJ 2003 Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocr Pract 9:204-209.
16. Giusti M, Cappi C, Santaniello B, Ceresola E, Augeri C, Lagasio C and Minuto F 2006 Safety and efficacy of administering 0.2mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goitre. Miner Endocrinol 31:191-209.
17. Braverman L, Kloos RT, Law B Jr., Kipnes M, Dionne M, Magner J 2008 Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters. Endocr Pract 14:832-839.
18. Fenzi GF, Ceccarelli C, Macchia E, Monzani F, Bartalena L, Giani C, Ceccarelli P, Lippi F, Baschieri L, Pinchera A 1985 Reciprocal changes of serum thyroglobulin and TSHin residents of a moderate endemic goitre area. Clin Endocrinol 23:115-122. (Pubitemid 15015332)
19. Huysmans AK, Hermus RM, Edelbroek MA, Tjabbes T, Oostdijk, Ross HA, Corstens FH, Kloppenborg PW 1997 Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goitres. Thyroid 7:535-539. (Pubitemid 27371789)
20. Nygaard B, Knudsen JH, Hegedus L, Scient AV, Hansen JE 1997 Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. J Clin Endocrinol Metab 82:2926-2930. (Pubitemid 27385650)
21. Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A 1998 Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid stimulating and thyrotropin-blocking antibodies and of radioiodineinduced thyroid damage. J Clin Endocrinol Metab 83: 40-46. (Pubitemid 28498308)
22. Rubio IG, Perone BH, Silva MN, Knobel M, Medeiros-Neto G 2005 Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies. Thyroid 15:134-139. (Pubitemid 40344361)